Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients

Table 1

Characteristics in KD patients resistant or sensitive to IVIG therapy.

Variables	IVIG-R^a	IVIG-S^b	value^c
Age range, month	1–116	1–156	0.0672
Mean ± SD	28.20 ± 24.40	26.58 ± 21.86
≤60	134 (90.54%)	579 (94.76%)
>60	14 (9.46%)	32 (5.24%)
Gender			0.5545
Male	97 (65.54%)	416 (68.09%)
Female	51 (34.46%)	195 (31.91%)

^aKD patients resistant to IVIG therapy. ^bKD patients sensitive to IVIG therapy. ^cTwo-sided χ² test for the distribution between KD patients with resistance or sensitivity to IVIG.